785 articles
Northwestern researchers uncover the brain biology and lifestyle traits behind SuperAgers who defy cognitive decline into their 80s.
Lifespan.io reviews top rejuvenation research advances including voice-based aging biomarkers and a rapamycin-exercise clinical trial.
Interim data from AACR 2026 show RZ-001 combo therapy achieved up to 61.5% response rate in hard-to-treat liver cancer patients.
Serif Biomedicines aims to create a new drug class combining mRNA and gene therapy benefits, targeting rare diseases and immune reprogramming.
A 12-week Omada Health study shows coaching and strength training dramatically improve fat loss and muscle retention alongside GLP-1 drugs.
Curve Biosciences uses AI and circulating DNA to detect organ-specific disease signals earlier than standard tests, validated in 1,482 patients.
AliveCor's CE-marked Kardia 12L brings full 12-lead ECG diagnostics to any clinic, cutting test time by a third with AI guidance.
A newly discovered bacteriophage inside common gut bacteria appears strongly linked to colorectal cancer, potentially explaining a long-standing medical paradox.
A small phase I trial found nivolumab injected into oral precancers shrank lesions in 85% of patients, offering a non-surgical alternative.
A low-dose three-drug pill slashed recurrent stroke risk and improved blood pressure control in intracerebral hemorrhage survivors, a major RCT found.
A surprising study found young lung cancer patients ate healthier diets, but experts warn against misreading the data.
Satralizumab slashed relapses in MOGAD by 68% in the first-ever positive RCT for this demyelinating disease.
